Alignment Healthcare (NASDAQ:ALHC) Sets New 1-Year Low – What’s Next?

Alignment Healthcare, Inc. (NASDAQ:ALHC)’s stock price reached a new 52-week low on Wednesday . The company traded as low as $13.05 and last traded at $13.1170, with a volume of 160212 shares changing hands. The stock had previously closed at $13.23.

Trending Headlines about Alignment Healthcare

Here are the key news stories impacting Alignment Healthcare this week:

• Positive Sentiment: Investors purchased 11,958 ALHC call options on August 19, roughly 11 times the stock’s average daily call volume. The activity may signal bullish positioning or expectations for increased volatility, although options flow alone does not confirm a fundamental improvement.
• Neutral Sentiment: Alignment Healthcare plans to present at the Baird 2026 Global Healthcare Conference and attend Morgan Stanley’s 24th Annual Global Healthcare Conference. These events could give management an opportunity to discuss growth, operating performance and strategy with institutional investors, but no new financial guidance was provided. Alignment Healthcare conference announcement
• Negative Sentiment: Kaplan Fox & Kilsheimer LLP announced that it is investigating Alignment Healthcare, its board and certain officers for possible securities-law violations, including on behalf of investors who may have suffered losses. The announcements do not establish wrongdoing, but the investigation could increase legal costs, create uncertainty and weigh on the stock if substantive claims or investor losses emerge. Multiple notices were issued on August 19–20, increasing the visibility of the overhang. Kaplan Fox investigation announcement

Analysts Set New Price Targets

A number of research analysts recently commented on the company. JPMorgan Chase & Co. decreased their price target on Alignment Healthcare from $26.00 to $22.00 and set an “overweight” rating on the stock in a research report on Tuesday, August 4th. KeyCorp reaffirmed an “overweight” rating on shares of Alignment Healthcare in a research report on Wednesday, June 10th. Barclays reduced their price objective on shares of Alignment Healthcare from $19.00 to $16.00 and set an “equal weight” rating on the stock in a research note on Tuesday, May 26th. Weiss Ratings restated a “hold (c-)” rating on shares of Alignment Healthcare in a research report on Tuesday, August 4th. Finally, Wall Street Zen downgraded shares of Alignment Healthcare from a “buy” rating to a “hold” rating in a report on Saturday, August 1st. Seven research analysts have rated the stock with a Buy rating and four have issued a Hold rating to the company’s stock. According to MarketBeat.com, the company has a consensus rating of “Moderate Buy” and a consensus target price of $23.60.

Alignment Healthcare Stock Up 1.2%

The company has a quick ratio of 1.70, a current ratio of 1.70 and a debt-to-equity ratio of 1.22. The firm has a 50 day moving average of $18.97 and a two-hundred day moving average of $18.87. The firm has a market capitalization of $2.68 billion, a price-to-earnings ratio of 68.06 and a beta of 1.10.

Alignment Healthcare (NASDAQ:ALHC) last issued its earnings results on Thursday, July 30th. The company reported $0.17 EPS for the quarter, topping the consensus estimate of $0.13 by $0.04. Alignment Healthcare had a return on equity of 20.02% and a net margin of 0.89%.The firm had revenue of $1.34 billion during the quarter, compared to the consensus estimate of $1.31 billion. During the same quarter in the previous year, the firm earned $0.07 earnings per share. The business’s quarterly revenue was up 31.6% on a year-over-year basis. As a group, sell-side analysts anticipate that Alignment Healthcare, Inc. will post 0.17 EPS for the current fiscal year.

Insiders Place Their Bets

In related news, insider Hyong Kim sold 35,951 shares of the business’s stock in a transaction on Friday, June 12th. The stock was sold at an average price of $19.86, for a total transaction of $713,986.86. Following the sale, the insider owned 331,750 shares in the company, valued at $6,588,555. The trade was a 9.78% decrease in their position. The sale was disclosed in a legal filing with the SEC, which is available at this hyperlink. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Also, insider Mark D. Kent acquired 14,848 shares of Alignment Healthcare stock in a transaction that occurred on Tuesday, June 2nd. The shares were purchased at an average price of $13.31 per share, for a total transaction of $197,626.88. Following the transaction, the insider directly owned 14,848 shares in the company, valued at $197,626.88. The trade was a ∞ increase in their ownership of the stock. The disclosure for this purchase is available in the SEC filing. Insiders have sold 1,009,951 shares of company stock worth $18,597,287 over the last 90 days. Insiders own 5.20% of the company’s stock.

Institutional Trading of Alignment Healthcare

Several hedge funds and other institutional investors have recently made changes to their positions in the company. Susquehanna Fundamental Investments LLC acquired a new position in shares of Alignment Healthcare in the second quarter valued at approximately $2,507,000. Benjamin Edwards Inc. boosted its position in Alignment Healthcare by 86.4% during the 2nd quarter. Benjamin Edwards Inc. now owns 50,200 shares of the company’s stock worth $1,195,000 after buying an additional 23,270 shares during the period. UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC grew its holdings in Alignment Healthcare by 8.1% during the 2nd quarter. UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC now owns 487,153 shares of the company’s stock worth $11,599,000 after acquiring an additional 36,625 shares during the last quarter. Hsbc Holdings PLC bought a new stake in Alignment Healthcare during the 2nd quarter worth approximately $1,765,000. Finally, Wellington Management Group LLP increased its position in Alignment Healthcare by 9.8% in the 2nd quarter. Wellington Management Group LLP now owns 18,780,363 shares of the company’s stock valued at $447,160,000 after acquiring an additional 1,681,427 shares during the period. 86.19% of the stock is currently owned by institutional investors.

About Alignment Healthcare

Alignment Healthcare, Inc (NASDAQ: ALHC) is a health care company specializing in value-based care for Medicare Advantage beneficiaries. The company leverages an integrated care model that combines in-home clinical services, telehealth capabilities and digital health tools to manage chronic conditions, improve outcomes and enhance patient experience.

At the core of Alignment Healthcare’s approach is a proprietary technology platform that aggregates real-time clinical and claims data to support preventive care, risk stratification and personalized care plans.